These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1599452)

  • 1. 31-P NMR characterization of the metabolic anomalies associated with the lack of glycogen phosphorylase activity in human forearm muscle.
    Bendahan D; Confort-Gouny S; Kozak-Ribbens G; Cozzone PJ
    Biochem Biophys Res Commun; 1992 May; 185(1):16-21. PubMed ID: 1599452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MR imaging as a potential diagnostic test for metabolic myopathies: importance of variations in the T2 of muscle with exercise.
    Jehenson P; Leroy-Willig A; de Kerviler E; Duboc D; Syrota A
    AJR Am J Roentgenol; 1993 Aug; 161(2):347-51. PubMed ID: 8333376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral nerve and vasculature involvement in myophosphorylase deficiency (McArdle's disease).
    Byard RW; Lach B; Preston DN
    Pathology; 1991 Jan; 23(1):62-5. PubMed ID: 2062570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impairment of sympathetic activation during static exercise in patients with muscle phosphorylase deficiency (McArdle's disease).
    Pryor SL; Lewis SF; Haller RG; Bertocci LA; Victor RG
    J Clin Invest; 1990 May; 85(5):1444-9. PubMed ID: 2332499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of functional messenger RNA for glycogen phosphorylase in the muscle of two patients with McArdle's disease.
    Daegelen D; Munnich A; Levin MJ; Girault A; Goasguen J; Kahn A; Dreyfus JC
    Ann Hum Genet; 1983 May; 47(2):107-15. PubMed ID: 6576726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of branched-chain amino acids and ammonia during exercise: clues from McArdle's disease.
    Wagenmakers AJ; Coakley JH; Edwards RH
    Int J Sports Med; 1990 May; 11 Suppl 2():S101-13. PubMed ID: 2193889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. McArdle's disease--what limit to the age of onset?
    Hewlett RH; Gardner-Thorpe C
    S Afr Med J; 1978 Jan; 53(2):60-3. PubMed ID: 273990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscle fatigue in McArdle's disease studied by 31P-NMR: effect of glucose infusion.
    Lewis SF; Haller RG; Cook JD; Nunnally RL
    J Appl Physiol (1985); 1985 Dec; 59(6):1991-4. PubMed ID: 3865926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscle energy metabolism in McArdle's syndrome by in vivo phosphorus magnetic resonance spectroscopy.
    Argov Z; Bank WJ; Maris J; Chance B
    Neurology; 1987 Nov; 37(11):1720-4. PubMed ID: 3478608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms of McArdle's disease (muscle glycogen phosphorylase deficiency). RNA and DNA analysis.
    Gautron S; Daegelen D; Mennecier F; Dubocq D; Kahn A; Dreyfus JC
    J Clin Invest; 1987 Jan; 79(1):275-81. PubMed ID: 3466902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic basis of improved exercise tolerance: muscle phosphorylase deficiency after glucagon administration.
    Kono N; Mineo I; Sumi S; Shimizu T; Kang J; Nonaka K; Tarui S
    Neurology; 1984 Nov; 34(11):1471-6. PubMed ID: 6593602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased muscular beta-hydroxyacyl CoA dehydrogenase with McArdle's disease.
    Turk WR; Heller SL; Norris BJ; Nemeth PM
    Muscle Nerve; 1990 Jul; 13(7):607-12. PubMed ID: 2388659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pi trapping in glycogenolytic pathway can explain transient Pi disappearance during recovery from muscular exercise. A 31P NMR study in the human.
    Bendahan D; Confort-Gouny S; Kozak-Reiss G; Cozzone PJ
    FEBS Lett; 1990 Sep; 269(2):402-5. PubMed ID: 2401366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus-mediated delivery into myocytes of muscle glycogen phosphorylase, the enzyme deficient in patients with glycogen-storage disease type V.
    Baqué S; Newgard CB; Gerard RD; Guinovart JJ; Gómez-Foix AM
    Biochem J; 1994 Dec; 304 ( Pt 3)(Pt 3):1009-14. PubMed ID: 7818463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myophosphorylase deficiency impairs muscle oxidative metabolism.
    Haller RG; Lewis SF; Cook JD; Blomqvist CG
    Ann Neurol; 1985 Feb; 17(2):196-9. PubMed ID: 3856415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. McArdle's disease: biochemical and molecular genetic studies.
    Servidei S; Shanske S; Zeviani M; Lebo R; Fletterick R; DiMauro S
    Ann Neurol; 1988 Dec; 24(6):774-81. PubMed ID: 3207360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [McArdle's disease without typical symptoms].
    Watanabe M; Matsubara E; Amari M; Okamoto K; Hirai S
    Rinsho Shinkeigaku; 1990 Nov; 30(11):1247-51. PubMed ID: 2085931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. McArdle's disease with late-onset symptoms: case report and review of the literature.
    Felice KJ; Schneebaum AB; Jones HR
    J Neurol Neurosurg Psychiatry; 1992 May; 55(5):407-8. PubMed ID: 1602316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pathophysiology of McArdle's disease: clues to regulation in exercise and fatigue.
    Lewis SF; Haller RG
    J Appl Physiol (1985); 1986 Aug; 61(2):391-401. PubMed ID: 3528113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytosolic pH buffering during exercise and recovery in skeletal muscle of patients with McArdle's disease.
    Kemp GJ; Tonon C; Malucelli E; Testa C; Liava A; Manners D; Trevisi E; Martinuzzi A; Barbiroli B; Lodi R
    Eur J Appl Physiol; 2009 Mar; 105(5):687-94. PubMed ID: 19066935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.